Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major medical society recommends the test for screening.

Identifying population-based eGFR distributions may help to identify patients at risk for developing chronic kidney disease earlier, according to study data published in Kidney International. More ...

Unlike compound bows, spotting scope manufacturers don’t release a new flagship model each year. In fact, many optic companies will go years between developing a new spotter. That’s why, as hunters, ...